Cargando…

CSF Levels of CXCL12 and Osteopontin as Early Markers of Primary Progressive Multiple Sclerosis

BACKGROUND AND OBJECTIVES: To evaluate the extent of intrathecal inflammation in patients with primary progressive MS (PPMS) at the time of diagnosis and to define markers and a specific inflammatory profile capable of distinguishing progressive from relapsing-remitting multiple sclerosis (RRMS). ME...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marastoni, Damiano, Magliozzi, Roberta, Bolzan, Anna, Pisani, Anna Isabella, Rossi, Stefania, Crescenzo, Francesco, Montemezzi, Stefania, Pizzini, Francesca Benedetta, Calabrese, Massimiliano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482414/ https://www.ncbi.nlm.nih.gov/pubmed/34588298 http://dx.doi.org/10.1212/NXI.0000000000001083

Ejemplares similares

CSF TNF and osteopontin levels correlate with the response to dimethyl fumarate in early multiple sclerosis
por: Marastoni, Damiano, et al.
Publicado: (2022)

Cerebrospinal Fluid IgM Levels in Association With Inflammatory Pathways in Multiple Sclerosis Patients
por: Magliozzi, Roberta, et al.
Publicado: (2020)

The Prognostic Value of White-Matter Selective Double Inversion Recovery MRI Sequence in Multiple Sclerosis: An Exploratory Study
por: Crescenzo, Francesco, et al.
Publicado: (2021)

CSF parvalbumin levels reflect interneuron loss linked with cortical pathology in multiple sclerosis
por: Magliozzi, Roberta, et al.
Publicado: (2021)

Iron homeostasis, complement, and coagulation cascade as CSF signature of cortical lesions in early multiple sclerosis
por: Magliozzi, Roberta, et al.
Publicado: (2019)

Increased NK Cell Count in Multiple Sclerosis Patients Treated With Dimethyl Fumarate: A 2-Year Longitudinal Study
por: Marastoni, Damiano, et al.
Publicado: (2019)

Intrathecal versus Peripheral Inflammatory Protein Profile in MS Patients at Diagnosis: A Comprehensive Investigation on Serum and CSF
por: Pezzini, Francesco, et al.
Publicado: (2023)

Changes in Cerebrospinal Fluid Balance of TNF and TNF Receptors in Naïve Multiple Sclerosis Patients: Early Involvement in Compartmentalised Intrathecal Inflammation
por: Magliozzi, Roberta, et al.
Publicado: (2021)

The Use of the Central Vein Sign in the Diagnosis of Multiple Sclerosis: A Systematic Review and Meta-analysis
por: Castellaro, Marco, et al.
Publicado: (2020)

Increase of CSF inflammatory profile in a case of highly active multiple sclerosis
por: Magliozzi, R., et al.
Publicado: (2019)

Frequency and severity of COVID-19 in multiple sclerosis: A short single-site report from northern Italy
por: Crescenzo, Francesco, et al.
Publicado: (2020)

Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study
por: Farina, Gabriele, et al.
Publicado: (2017)

“Ependymal‐in” Gradient of Thalamic Damage in Progressive Multiple Sclerosis
por: Magliozzi, Roberta, et al.
Publicado: (2022)

A novel prognostic score to assess the risk of progression in relapsing−remitting multiple sclerosis patients
por: Pisani, Anna Isabella, et al.
Publicado: (2021)

Association of circulating CXCL10 and CXCL11 with systemic sclerosis
por: Crescioli, Clara, et al.
Publicado: (2018)

Atypical myelin oligodendrocyte glycoprotein antibody–associated optic neuritis and acute demyelinating polyneuropathy after SARS-CoV-2 infection: Case report and literature review
por: Bosello, Francesca, et al.
Publicado: (2023)

Chronic Bedridden Condition Is Reflected by Substantial Changes in Plasma Inflammatory Profile
por: Magliozzi, Roberta, et al.
Publicado: (2022)

Immune Response after COVID-19 mRNA Vaccination in Multiple Sclerosis Patients Treated with DMTs
por: Mazziotti, Valentina, et al.
Publicado: (2022)

Microstructural MRI Correlates of Cognitive Impairment in Multiple Sclerosis: The Role of Deep Gray Matter
por: Pitteri, Marco, et al.
Publicado: (2021)

Clinical, MRI, and CSF Markers of Disability Progression in Multiple Sclerosis
por: Gajofatto, Alberto, et al.
Publicado: (2013)

Osteopontin (OPN) as a CSF and blood biomarker for multiple sclerosis: A systematic review and meta-analysis
por: Agah, Elmira, et al.
Publicado: (2018)

CSF CXCL13 and Chitinase 3-like-1 Levels Predict Disease Course in Relapsing Multiple Sclerosis
por: Lucchini, Matteo, et al.
Publicado: (2022)

CXCR4-CXCL12-CXCR7 and PD-1/PD-L1 in Pancreatic Cancer: CXCL12 Predicts Survival of Radically Resected Patients
por: D’Alterio, Crescenzo, et al.
Publicado: (2022)

Making Visible the Invisible: Automatically Measured Global and Regional Brain Volume Is Associated with Cognitive Impairment and Fatigue in Multiple Sclerosis
por: Ziccardi, Stefano, et al.
Publicado: (2022)

Are CSF CXCL13 concentrations solely dependent on intrathecal production? A commentary on “Chemokine CXCL13 in serum, CSF, and blood–CSF barrier function”
por: DiSano, Krista D., et al.
Publicado: (2021)

CXCL12 and osteopontin from bone marrow-derived mesenchymal stromal cells improve muscle regeneration
por: Maeda, Yasushi, et al.
Publicado: (2017)

Osteopontin Is Associated with Multiple Sclerosis Relapses
por: Stampanoni Bassi, Mario, et al.
Publicado: (2023)

Chemokine CXCL13 in serum, CSF and blood–CSF barrier function: evidence of compartment restriction
por: Pilz, Georg, et al.
Publicado: (2020)

“What Is Hidden behind the Mask?” Facial Emotion Recognition at the Time of COVID-19 Pandemic in Cognitively Normal Multiple Sclerosis Patients
por: Ziccardi, Stefano, et al.
Publicado: (2021)

Osteopontin Links Myeloid Activation and Disease Progression in Systemic Sclerosis
por: Gao, Xia, et al.
Publicado: (2020)

Macrophages may promote cancer growth via a GM-CSF/HB-EGF paracrine loop that is enhanced by CXCL12
por: Rigo, Antonella, et al.
Publicado: (2010)

CXCL12 loaded-dermal filler captures CXCR4 expressing melanoma circulating tumor cells
por: Ieranò, Caterina, et al.
Publicado: (2019)

Osteopontin in Systemic Sclerosis and its Role in Dermal Fibrosis
por: Wu, Minghua, et al.
Publicado: (2012)

CXCL13 and CXCL9 CSF Levels in Central Nervous System Lymphoma—Diagnostic, Therapeutic, and Prognostic Relevance
por: Masouris, Ilias, et al.
Publicado: (2021)

CSF Concentrations of CXCL13 and sCD27 Before and After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis
por: Lundblad, Katarina, et al.
Publicado: (2023)

Intrathecal Inflammation in Progressive Multiple Sclerosis
por: Monaco, Salvatore, et al.
Publicado: (2020)

Regional Distribution and Evolution of Gray Matter Damage in Different Populations of Multiple Sclerosis Patients
por: Calabrese, Massimiliano, et al.
Publicado: (2015)

Extracellular proteasome-osteopontin circuit regulates cell migration with implications in multiple sclerosis
por: Dianzani, Chiara, et al.
Publicado: (2017)

The effect of osteopontin and osteopontin-derived peptides on preterm brain injury
por: Albertsson, Anna-Maj, et al.
Publicado: (2014)

The Vascular Side of Chronic Bed Rest: When a Therapeutic Approach Becomes Deleterious
por: Pedrinolla, Anna, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rj0bp3s96menvqp49ehv2b73q5